OBJECTIVES: Attitudes towards medication are believed to be important for medication adherence and social factors are believed to have effects on attitudes. Only a limited literature has focused on how attitudes to medication may correlate with social factors relevant to medication adherence among individuals with bipolar disorder (BPD). This secondary analysis of baseline data from a longitudinal study examined the relationships between attitudes towards mood stabilizers and psychosocial variables. METHODS: Community mental health clinic patients (n = 122) were assessed on the outcome variable of medication attitudes as measured by the Attitudes towards Mood Stabilizers Questionnaire (AMSQ). Independent variables included education as well as standardized measures of psychiatric symptom severity, alcohol and drug problem severity, health locus of control (the belief that one's health is self-determined versus determined by factors outside of one's own control), and psychosocial support. A hierarchical multiple regression model evaluated the relationship between AMSQ and these variables. RESULTS: More positive medication attitudes were seen in individuals with higher levels of social support and in those who held a stronger belief that their health outcomes are determined by others, such as family or clinicians. Education, symptom severity, alcohol problem severity and drug problem severity were not significant attitudinal correlates. CONCLUSIONS: Attitudes towards mood stabilizers are correlated with both the support a person receives from others in their social network and how much a person believes others can influence his or her health. Clinicians need to be aware of the importance of the social environment as it relates to medication attitudes and more research is needed on how treatment attitudes may actually translate into medication adherence behavior.
OBJECTIVES: Attitudes towards medication are believed to be important for medication adherence and social factors are believed to have effects on attitudes. Only a limited literature has focused on how attitudes to medication may correlate with social factors relevant to medication adherence among individuals with bipolar disorder (BPD). This secondary analysis of baseline data from a longitudinal study examined the relationships between attitudes towards mood stabilizers and psychosocial variables. METHODS: Community mental health clinic patients (n = 122) were assessed on the outcome variable of medication attitudes as measured by the Attitudes towards Mood Stabilizers Questionnaire (AMSQ). Independent variables included education as well as standardized measures of psychiatric symptom severity, alcohol and drug problem severity, health locus of control (the belief that one's health is self-determined versus determined by factors outside of one's own control), and psychosocial support. A hierarchical multiple regression model evaluated the relationship between AMSQ and these variables. RESULTS: More positive medication attitudes were seen in individuals with higher levels of social support and in those who held a stronger belief that their health outcomes are determined by others, such as family or clinicians. Education, symptom severity, alcohol problem severity and drug problem severity were not significant attitudinal correlates. CONCLUSIONS: Attitudes towards mood stabilizers are correlated with both the support a person receives from others in their social network and how much a person believes others can influence his or her health. Clinicians need to be aware of the importance of the social environment as it relates to medication attitudes and more research is needed on how treatment attitudes may actually translate into medication adherence behavior.
Authors: Kavi K Devulapalli; Rosalinda V Ignacio; Peter Weiden; Kristin A Cassidy; Tiffany D Williams; Roknedin Safavi; Frederic C Blow; Martha Sajatovic Journal: Psychopharmacol Bull Date: 2010
Authors: Christian J Teter; Anthony E Falone; Amanda M Bakaian; Chunhao Tu; Dost Ongür; Roger D Weiss Journal: Psychiatry Res Date: 2011-06-22 Impact factor: 3.222
Authors: Dawn I Velligan; Peter J Weiden; Martha Sajatovic; Jan Scott; Daniel Carpenter; Ruth Ross; John P Docherty Journal: J Clin Psychiatry Date: 2009 Impact factor: 4.384
Authors: Jose Ángel Alcalá; Andrés Fontalba-Navas; Miguel Company-Morales; Samuel L Romero-Guillena; Teófilo Gutiérrez-Higueras; Luis Gutiérrez-Rojas Journal: Int J Environ Res Public Health Date: 2022-06-22 Impact factor: 4.614
Authors: Peter Klein; Michelle E Aebi; Martha Sajatovic; Colin Depp; David Moore; Carol Blixen; Jennifer B Levin Journal: J Behav Cogn Ther Date: 2020-07-17
Authors: Jennifer B Levin; Michelle E Aebi; Molly Howland; Marina Barboza; Logan Eskew; Curtis Tatsuoka; Kristin A Cassidy; Martha Sajatovic Journal: J Nerv Ment Dis Date: 2020-02 Impact factor: 1.899
Authors: Jennifer B Levin; David J Moore; Colin Depp; Jessica L Montoya; Farren Briggs; Mahboob Rahman; Kurt C Stange; Douglas Einstadter; Celeste Weise; Carla Conroy; Joy Yala; Ethan Radatz; Martha Sajatovic Journal: Trials Date: 2022-06-29 Impact factor: 2.728